No Effect of Anti-Interleukin-5 Therapy (Mepolizumab) on the Atopy Patch Test in Atopic Dermatitis Patients

By  

International Archives of Allergy and Immunology, Vol. 141, Iss. 3, 2006-10 ,pp. : 290-294

Karger

Access to resources Recommend Favorite

Immunological changes after ASIT in AD allergen‐specific immunotherapy and their potential correlation with clinical response in patients with atopic dermatitis patients sensitized to house dust mite

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 7, 2015-07 ,pp. : 1318-1324

John Wiley & Sons Inc

Access to resources Recommend Favorite

Spreading of pre‐existing segmental vitiligo after immunotherapy with house dust mite in a patient with atopic dermatitis

By  

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 40, Iss. 8, 2015-12 ,pp. : 920-921

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reduction of Environmental Mites Improved Atopic Dermatitis Patients with Positive Mite‐patch Tests

By  

THE JOURNAL OF DERMATOLOGY, Vol. 19, Iss. 3, 1992-03 ,pp. : 177-180

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study

By Cadario Gianni   Galluccio Antonia G.   Pezza Michele   Appino Antonella   Milani Massimo   Pecora Silvia   Mastrandrea Fulvio  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2503-2506

Informa Healthcare

Access to resources Recommend Favorite